Two sets of data from VENUS (VESIcare Efficacy and Safety ...
For Immediate Release
NEWLY PRESENTED DATA ON VESICARE® (solifenacin succinate) SHOW SIGNIFICANT IMPROVEMENTS IN URGENCY FOR PATIENTS WITH OVERACTIVE BLADDER
- VESIcare is the First Overactive Bladder Treatment At An Approved Dose to Show a Statistically Significant Increase In Warning Time Before Urination-
Christchurch, New Zealand – December 1, 2006 – Patients with overactive bladder (OAB) treated with VESIcare® (solifenacin succinate) experienced statistically significant reductions in episodes of urgency (the sudden, compelling need to urinate), according to a new study presented today at the 36th Annual Meeting of the International Continence Society.
A secondary endpoint from this study also presented today demonstrated that patients taking VESIcare experienced a statistically significant increase in warning time – compared with patients taking placebo (31.5 seconds vs. 12.0 seconds median increase, respectively; p ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- exporting data from a pdf to excel
- types of data sets in healthcare
- the efficacy and effectiveness of treatment
- intersection of two sets calculator
- words with two sets of double letters
- definition of quality and safety in nursing
- vlookup to compare two sets of data
- efficacy and effectiveness
- efficacy and effectiveness difference
- union of two sets calculator
- comparing two sets of data in excel
- difference between efficacy and effectiveness